Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aurora CannabisACB -0.71%57 3-Year Share Buyback Ratio is -25.60 as of Mar. 2026. GuruFocus rates ACB with a GF Score™ of 57/100 and a GF Value™ of $4.28 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 648 Drug Manufacturers companies, Aurora Cannabis ranks worse than 87.04% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Aurora Cannabis's current 3-Year Share Buyback Ratio was -25.60%.
The historical rank and industry rank for Aurora Cannabis's 3-Year Share Buyback Ratio or its related term are showing as below:
ACB'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -143 Med: -53.85 Max: -0.5
Current: -25.6
During the past 13 years, Aurora Cannabis's highest 3-Year Share Buyback Ratio was -0.50%. The lowest was -143.00%. And the median was -53.85%.
ACB's 3-Year Share Buyback Ratio is ranked worse than 87.04% of 648
companies
in the Drug Manufacturers industry
Industry Median: -2
vs ACB: -25.60
Aurora Cannabis (NAS:ACB) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Aurora Cannabis 3-Year Share Buyback Ratio Related Terms
ACB vs ZTS: 3-Year Share Buyback Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Aurora Cannabis's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurora Cannabis 3-Year Share Buyback Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aurora Cannabis's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Aurora Cannabis's 3-Year Share Buyback Ratio falls into.
Aurora Cannabis 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of -25.60 mean?
Aurora Cannabis (ACB) has a 3-Year Share Buyback Ratio of -25.60 as of Mar. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Aurora Cannabis and its competitors. According to the industry distribution chart, Aurora Cannabis ranks #564 out of 648 companies in the Drug Manufacturers industry, placing it in the top 87%.
Is Aurora Cannabis' 3-Year Share Buyback Ratio too high?
Aurora Cannabis' current 3-Year Share Buyback Ratio is -25.60. Based on the distribution chart, Aurora Cannabis ranks #564 out of 648 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Aurora Cannabis has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Cannabis' 3-Year Share Buyback Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Aurora Cannabis ranks #564 out of 648 companies for 3-Year Share Buyback Ratio. This places Aurora Cannabis in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Drug Manufacturers company?
A good 3-Year Share Buyback Ratio depends on the Drug Manufacturers industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Aurora Cannabis and its competitors. Aurora Cannabis's current 3-Year Share Buyback Ratio is -25.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Aurora Cannabis (ACB) is currently considered Possible Value Trap. The stock's GF Value™ is $4.28, compared to a current price of $2.80 — trading 34.6% below its estimated fair value. The current 3-Year Share Buyback Ratio is -25.60. Aurora Cannabis' overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Aurora Cannabis (ACB), the current 3-Year Share Buyback Ratio is -25.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurora Cannabis (ACB) Overvalued in 2026?
Based on GuruFocus' analysis, Aurora Cannabis stock appears to be undervalued.
The current stock price of $2.80 is trading 34.6% below its estimated GF Value™ of $4.28.
GuruFocus considers Aurora Cannabis to be Possible Value Trap.
Key valuation signals for ACB:
3-Year Share Buyback Ratio: -25.60
GF Value™: $4.28 vs. price of $2.80 (34.6% below fair value)
No single metric tells the full story. See the ACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
57GF Score
Get the complete analysis for ACB
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACB has been successfully added to your 
